From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
IntegriChain has been instrumental in helping us navigate government programs. We thought we were on the right program path, but with the new CMS final rule, IntegriChain helped us quickly shift our strategy.
Government Reporting and Revenue Manager
While a strong pharma pricing and contracting strategy can play a major role in nearly every aspect of drug commercialization, manufacturers often lack efficient processes to interpret, create, and manage contracts; navigate new regulations; and comply with all local, county, state, and federal laws. Manufacturers who rely on piecemeal processes leave themselves vulnerable to increased risk, delays, compliance violations, and revenue leakage.
Successful pharmaceutical manufacturers can achieve contracting excellence by choosing a partner that can manage regulatory process and compliance standards across government price, rebate, and chargeback management that can easily be maintained and adhere to growing demand.
IntegriChain’s pricing and contracting strategic services provide pharmaceutical manufacturers with the following resources and outcomes:
Solve Government Pricing Complexities
Pharmaceutical rebates, originally created to better align the incentives of payers and providers, have now become an essential element of complex commercial and government access challenges. This complex rebate process makes it extremely difficult for manufacturers to focus their time and resources on business processes and managed market strategies.
As a trusted partner for government pricing as well as rebate management, IntegriChain processes hundreds of thousands of claims for a wide range of common fees annually. With modules to support different rebate types, manufacturers can scale their payer analytics and contracting functions.
Streamline Rebate Management
Chargebacks are a constant source of material business risk and revenue leakage. Because chargeback errors persist for a multitude of reasons, all pharmaceutical manufacturers that pay fees need a tool to verify contract compliance, otherwise they could be paying triple what they should.
Manage Your Chargeback Data
Get Pharma Pricing & Contracts Consulting
IntegriChain subject matter experts discuss the current status of drug pricing transparency laws that have been recently introduced and updated at the state level. Topics include disclosures themes, types of reports, and new reporting updates for nearly a dozen states. Watch THE WEBINAR
With a growing population of program participants, the amount of Claim Level Data (CLD) will continue to grow exponentially. Invoice level validations alone cannot bring to light all the potential disputes in the Medicaid data. Without a solid CLD strategy in place, manufacturers are prone to errors and significant revenue leakage. READ the eBOOK
